Avalon Pharma Reports SAR 55.70M Net Profit in the Six Months 2026
AVALON PHARMA 4016.SA | 0.00 |
On 2026-08-06 08:03:53 (Saudi Time), Middle East Pharmaceutical Industries Co. announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 136.48 | 117.66 | 15.995 | 130.13 | 4.879 |
| Gross Profit (Loss) | 85.49 | 73.63 | 16.107 | 80.62 | 6.04 |
| Operational Profit (Loss) | 34.16 | 28.26 | 20.877 | 30.72 | 11.197 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 28.8 | 24.81 | 16.082 | 26.9 | 7.063 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 28.1 | 22.57 | 24.501 | 27.61 | 1.774 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 266.61 | 215.02 | 23.993 |
| Gross Profit (Loss) | 166.11 | 133.9 | 24.055 |
| Operational Profit (Loss) | 64.88 | 50.56 | 28.322 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 55.7 | 44.21 | 25.989 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 55.7 | 41.96 | 32.745 |
| Total Shareholders Equity (after Deducting Minority Equity) | 445.55 | 385.17 | 15.676 |
| Profit (Loss) per Share | 1.59 | 1.26 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For the six-month period ending 30 June 2026 (H1 2026), Middle East Pharmaceutical Industries Company (Avalon Pharma) reported revenue of SAR 266.61 million, up 23.993% YoY from SAR 215.02 million in H1 2025, primarily driven by strong growth in the Private segment (SAR 191.7 million, +32.6% YoY), supplemented by the Public segment (SAR 52.3 million, +5.7% YoY) on the back of increased government tender awards, and the Export segment (SAR 22.6 million, +7.5% YoY). Net profit attributable to shareholders grew 25.989% YoY to SAR 55.7 million from SAR 44.21 million, with net profit margin improving to 20.9% from 20.6%, supported by the strong revenue growth, a favorable product mix, and continued operational efficiencies across the Company.
Quarter-on-Quarter Performance Drivers
QoQ revenue rose 4.9% to SAR 136.48 million in Q2 2026 from SAR 130.13 million in Q1 2026, driven primarily by growth in the Private segment (up 8.6% QoQ to SAR 99.8 million) and a sharp recovery in the Export segment (SAR 18.0 million vs. SAR 4.6 million in Q1 2026) following strategic rescheduling undertaken in the prior quarter. Net profit increased 7.1% QoQ to SAR 28.8 million from SAR 26.9 million, supported by the revenue growth and lower General & Administrative expenses, while net profit margin improved to 21.1% from 20.7%. The profitability improvement was partially offset by higher Selling & Distribution expenses as the Company continued to invest in business expansion.
Other Items
The external auditor issued an unmodified conclusion with no additional comments, reservations, or adverse opinions noted. No material risks, going concern uncertainties, or debt covenant breaches were flagged in the report. Total shareholders' equity (after deducting minority equity) stood at SAR 445.55 million as of the current period, compared to SAR 385.17 million in the same period of the prior year, representing a 15.676% increase. Earnings per share for H1 2026 were SAR 1.59, up from SAR 1.26 in H1 2025. No reclassification of comparison items was reported, and no additional information was disclosed.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97322&anCat=1&cs=4016&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/25633_5507_2026-08-05_16-52-21_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.